Dr. Reddy's launches Carboprost Tromethamine Injection USP

03 Jul 2019 Evaluate

Dr. Reddy's Laboratories has launched Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate injection, 250 mcg/mL, approved by the US Food and Drug Administration (USFDA).

The Hemabate injection, 250 mcg/mL brand had US sales of approximately $55 million MAT for the most recent twelve months ending in April 2019 according to IQVIA Health.

Dr. Reddy's Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) contains carboprost tromethamine equivalent to 250 mcg of carboprost.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

6292.70 -57.25 (-0.90%)
06-May-2024 15:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.50
Dr. Reddys Lab 6292.70
Cipla 1421.00
Zydus Lifesciences 1017.10
Lupin 1673.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.